重症监护病房入院后90天存活且在家天数与机械通气患者长期生存及功能状态的相关性
RECOVER前瞻性队列研究纳入加拿大10个ICU中年龄≥16岁、接受有创机械通气≥7天的患者,基线队列463例,随访队列292例。在存活至90天的患者中,DAAH90较低与1年死亡风险升高相关(三分位1 vs 三分位3:校正HR 0.18,95%CI 0.07-0.43;P<.001),并与3个月时FIM、6MWT、MRC、SF-36 PCS评分较低独立相关。存活至12个月者中,DAAH90三分位3 vs 三分位1与12个月FIM评分较高相关,但与第28天无呼吸机天数、无ICU天数无关。作者认为DAAH90比标准临床终点更好地反映长期功能状态,或可作为未来临床试验中以患者为中心的终点。
要点
- 存活至90天的机械通气患者中,DAAH90三分位1 vs 三分位3的1年死亡率校正HR为0.18(95%CI 0.07-0.43;P<.001),即DAAH90较低与1年死亡风险升高独立相关。
- 3个月随访时,DAAH90三分位1 vs 三分位3的FIM中位评分为76(IQR 46.2-101)vs 121(IQR 112-124.2)(P=.04)。
- 3个月时6MWT三分位1 vs 三分位3为98(IQR 0-239)vs 402(IQR 300-494)(P<.001),MRC为48(IQR 32-54)vs 58(IQR 51-60)(P<.001),SF-36 PCS为30(IQR 22-38)vs 37(IQR 31-47)(P=.001)。
- 存活至12个月者中,DAAH90三分位3 vs 三分位1与12个月FIM评分较高相关(估计值22.4,95%CI 14.8-30.0;P<.001),但与第28天无呼吸机天数(估计值6.0,95%CI -2.2至14.1;P=.15)及无ICU天数(估计值5.9,95%CI -2.1至13.8;P=.15)无关。
- 基线队列中,Charlson合并症指数评分、APACHE II评分、ICU干预(如肾脏替代治疗或气管切开)及ICU住院时长与较低的DAAH90独立相关。
适用人群与场景
- 基线队列:加拿大10个ICU中年龄≥16岁、接受有创机械通气≥7天的患者,共463例,中位年龄58岁(IQR 47-68岁),男性278例(60.0%)。
- 随访队列:基线队列中存活至3、6、12个月且功能结局可评估的RECOVER患者,共292例,中位年龄57岁(IQR 46-65岁),男性169例(57.9%)。
研究设计与关键结果
- 研究设计:RECOVER前瞻性队列研究的二次数据分析,2007年2月至2014年3月在加拿大10个ICU开展,二次分析时间为2021年7月至2022年8月。
- 暴露:ICU入院后90天存活且在家天数(DAAH90)三分位。
- 主要结局:存活至90天的患者中,DAAH90三分位1 vs 三分位3的1年死亡率校正HR为0.18(95%CI 0.07-0.43;P<.001)。
- 3个月功能结局(三分位1 vs 三分位3):FIM中位76(IQR 46.2-101)vs 121(IQR 112-124.2),P=.04;6MWT中位98(IQR 0-239)vs 402(IQR 300-494),P<.001;MRC中位48(IQR 32-54)vs 58(IQR 51-60),P<.001;SF-36 PCS中位30(IQR 22-38)vs 37(IQR 31-47),P=.001。
- 存活至12个月者中,DAAH90三分位3 vs 三分位1与12个月FIM评分较高相关(估计值22.4,95%CI 14.8-30.0;P<.001),但与第28天无呼吸机天数(估计值6.0,95%CI -2.2至14.1;P=.15)及无ICU天数(估计值5.9,95%CI -2.1至13.8;P=.15)无关。
- 基线队列中,Charlson合并症指数评分、APACHE II评分、ICU干预(如肾脏替代治疗或气管切开)及ICU住院时长与较低的DAAH90独立相关。
证据类型、等级与局限
- 证据类型:前瞻性队列研究的二次数据分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,DAAH90终点比标准临床终点更好地反映ICU研究中的长期功能状态,或可作为未来临床试验中以患者为中心的终点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Many conventional end points in randomized clinical trials of interventions for critically ill patients do not account for patient-centered concerns such as time at home, physical function, and quality of life after critical illness.
OBJECTIVE: To establish whether days alive and at home at day 90 (DAAH90) is associated with long-term survival and functional outcomes in mechanically ventilated patients.
DESIGN, SETTING, AND PARTICIPANTS: The RECOVER prospective cohort study was conducted from February 2007 to March 2014, using data from 10 intensive care units (ICUs) in Canada. Patients were included in the baseline cohort if they were aged 16 years or older and underwent invasive mechanical ventilation for 7 or more days. The follow-up cohort analyzed here comprised RECOVER patients who were alive and had functional outcomes ascertained at 3, 6, and 12 months. Secondary data analysis occurred from July 2021 to August 2022.
EXPOSURES: Composite of survival and days alive and at home at day 90 after ICU admission (DAAH90).
MAIN OUTCOMES AND MEASURES: Functional outcomes at 3, 6, and 12 months were evaluated with the Functional Independence Measure (FIM), the 6-Minute Walk Test (6MWT), the Medical Research Council (MRC) Scale for Muscle Strength, and the 36-Item Short Form Health Survey physical component summary (SF-36 PCS). Mortality was evaluated at 1 year from ICU admission. Ordinal logistic regression was used to describe the association between DAAH90 tertiles and outcomes. Cox proportional hazards regression models were used to examine the independent association of DAAH90 tertiles with mortality.
RESULTS: The baseline cohort comprised 463 patients. Their median age was 58 years (IQR, 47-68 years), and 278 patients (60.0%) were men. In these patients, Charlson Comorbidity Index score, Acute Physiology and Chronic Health Evaluation II score, ICU intervention (eg, kidney replacement therapy or tracheostomy), and ICU length of stay were independently associated with lower DAAH90. The follow-up cohort comprised 292 patients. Their median age was 57 years (IQR, 46-65 years), and 169 patients (57.9%) were men. Among patients who survived to day 90, lower DAAH90 was associated with higher mortality at 1 year after ICU admission (tertile 1 vs tertile 3: adjusted hazard ratio [HR], 0.18 [95% CI, 0.07-0.43]; P < .001). At 3 months of follow-up, lower DAAH90 was independently associated with lower median scores on the FIM (tertile 1 vs tertile 3, 76 [IQR, 46.2-101] vs 121 [IQR, 112-124.2]; P = .04), 6MWT (tertile 1 vs tertile 3, 98 [IQR, 0-239] vs 402 [IQR, 300-494]; P < .001), MRC (tertile 1 vs tertile 3, 48 [IQR, 32-54] vs 58 [IQR, 51-60]; P < .001), and SF-36 PCS (tertile 1 vs tertile 3, 30 [IQR, 22-38] vs 37 [IQR, 31-47]; P = .001) measures. Among patients who survived to 12 months, being in tertile 3 vs tertile 1 for DAAH90 was associated with higher FIM score at 12 months (estimate, 22.4 [95% CI, 14.8-30.0]; P < .001), but this association was not present for ventilator-free days (estimate, 6.0 [95% CI, -2.2 to 14.1]; P = .15) or ICU-free days (estimate, 5.9 [95% CI, -2.1 to 13.8]; P = .15) at day 28.
CONCLUSIONS AND RELEVANCE: In this study, lower DAAH90 was associated with greater long-term mortality risk and worse functional outcomes among patients who survived to day 90. These findings suggest that the DAAH90 end point reflects long-term functional status better than standard clinical end points in ICU studies and may serve as a patient-centered end point in future clinical trials.
参考来源
- Taran S, Coiffard B, Huszti E, et al. Association of Days Alive and at Home at Day 90 After Intensive Care Unit Admission With Long-term Survival and Functional Status Among Mechanically Ventilated Patients. JAMA Netw Open. 2023. PMID: 36929399. doi:10.1001/jamanetworkopen.2023.3265
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。